Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : GILD exchanges : Amex save search
Matinas BioPharma Reports Third Quarter 2021 Financial Results and Operational Highlights
Published: 2021-11-08 (Crawled : 12:00) - globenewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 0.16%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.12%
H: 0.0%
C: 0.0%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 0.05%
H: 0.0%
C: 0.0%
MTNB | $0.1877 -1.21% 0.0% 330K
|
Health Technology
|
| O: -2.78%
H: 2.86%
C: -3.81%
biopharma financial results results
Matinas BioPharma Announces Collaboration with the National Institute of Allergy and Infectious Diseases to Evaluate Oral Formulations of Gilead’s Antiviral Remdesivir Utilizing Matinas’ LNC Platform Delivery Technology
Published: 2020-12-07 (Crawled : 12:00) - globenewswire.com
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 0.17%
H: 0.06%
C: -1.35%
MTNB | $0.1877 -1.21% 0.0% 330K
|
Health Technology
|
| O: 10.09%
H: 4.17%
C: -7.5%
biopharma collaboration disease announces collaboration liver infectious disease antiviral
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.